|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
FY2015
12 months to Dec 31, 2015
|
FY2014
12 months to Dec 31, 2014
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net (losses)/earnings | |||||
| Less: Net (losses)/earnings from discontinued operations, net of tax | |||||
| (Losses)/earnings from continuing operations | |||||
| Adjustments to reconcile net (losses)/earnings to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Impairment of goodwill | |||||
| Impairment of property, plant and equipment and other assets | |||||
| (Gain)/loss on disposal of property, plant and equipment and equity method investments | |||||
| Gain on extinguishment of debt | |||||
| Insurance gain recorded in other operating income | |||||
| (Earnings)/losses from unconsolidated companies, net of tax | |||||
| Amortization of debt issuance costs and discount on secured term loan | |||||
| Share-based compensation | |||||
| Change in provisions for uncertain tax positions | |||||
| Benefit from deferred income tax | |||||
| Other non-cash movements | |||||
| Effect of exchange rates on net (losses)/earnings | |||||
| Change in assets and liabilities, net of effects from acquisitions: | |||||
| Accounts receivable | |||||
| Due from unconsolidated companies | |||||
| Prepaid expense and other | |||||
| Inventories | |||||
| Escrow and prepaid customer deposits | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Deferred revenue | |||||
| Other liabilities | |||||
| Other, net | |||||
| Other cash movements: | |||||
| Dividends from equity method investees | |||||
| Proceeds from insurance settlements | |||||
| Payment of key money | |||||
| Proceeds from swap termination | |||||
| Payment of swap termination costs | |||||
| Net cash provided by operating activities from continuing operations | |||||
| Net cash (used in)/provided by operating activities from discontinued operations | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditure to acquire property, plant and equipment | |||||
| Capital expenditure to acquire intangible assets | |||||
| Acquisitions, net of cash acquired | |||||
| Investments in unconsolidated companies | |||||
| Increase in restricted cash | |||||
| Release of restricted cash | |||||
| Change in deferred revenue for asset sale deposits | |||||
| Proceeds from sale of business | |||||
| Proceeds from insurance settlements | |||||
| Proceeds from sale of property, plant and equipment and equity method investments | |||||
| Net cash used in investing activities from continuing operations | |||||
| Net cash provided by investing activities from discontinued operations | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Payments on working capital facilities | |||||
| Repurchase of shares | |||||
| Exercised stock options and vested share awards | |||||
| Dividend to non-controlling interest | |||||
| Issuance of long-term debt | |||||
| Debt issuance costs | |||||
| Principal payments under long-term debt | |||||
| Net cash provided by financing activities from continuing operations | |||||
| Net cash provided by financing activities from discontinued operations | |||||
| Net cash provided by financing activities | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period (includes $Nil, $Nil and $Nil of cash presented within assets held for sale) | |||||
| Cash and cash equivalents at end of period (includes $Nil, $Nil, $Nil of cash presented within assets held for sale) | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net (decrease)/increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period (includes $Nil, $Nil and $Nil of cash presented within assets held for sale) | |||||
| Cash, cash equivalents and restricted cash at end of period (includes $Nil, $Nil, $Nil of cash presented within assets held for sale) | |||||
Loading...